These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 37796169

  • 1. Sweroside attenuates podocyte injury and proteinuria in part by activating Akt/BAD signaling in mice.
    Huang M, Yang Y, Chen Y, Li Y, Qin S, Xiao L, Long X, Hu K, Li Y, Ying H, Ding Y.
    J Cell Biochem; 2023 Nov; 124(11):1749-1763. PubMed ID: 37796169
    [Abstract] [Full Text] [Related]

  • 2. Neuregulin 4 Attenuates Podocyte Injury and Proteinuria in Part by Activating AMPK/mTOR-Mediated Autophagy in Mice.
    Deng J, Yang Q, Zhu W, Zhang Y, Lin M, She J, Li J, Xiao Y, Xiao J, Xu X, He H, Zhu B, Ding Y.
    J Cell Biochem; 2024 Oct; 125(10):e30634. PubMed ID: 39091188
    [Abstract] [Full Text] [Related]

  • 3. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
    He M, Li Y, Wang L, Guo B, Mei W, Zhu B, Zhang J, Ding Y, Meng B, Zhang L, Xiang L, Dong J, Liu M, Xiang L, Xiang G.
    Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
    [Abstract] [Full Text] [Related]

  • 4. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury.
    Zhang J, Fu H, Xu Y, Niu Y, An X.
    J Nat Med; 2016 Oct; 70(4):740-8. PubMed ID: 27255369
    [Abstract] [Full Text] [Related]

  • 5. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
    Lu J, Chen PP, Zhang JX, Li XQ, Wang GH, Yuan BY, Huang SJ, Liu XQ, Jiang TT, Wang MY, Liu WT, Ruan XZ, Liu BC, Ma KL.
    Theranostics; 2021 Oct; 11(10):4728-4742. PubMed ID: 33754024
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The PI3K/p-Akt signaling pathway participates in calcitriol ameliorating podocyte injury in DN rats.
    Song Z, Guo Y, Zhou M, Zhang X.
    Metabolism; 2014 Oct; 63(10):1324-33. PubMed ID: 25044177
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
    Huang Z, Peng Y, Yu H, Yu X, Zhou J, Xiao J.
    Biochem Biophys Res Commun; 2018 Oct 12; 504(4):949-956. PubMed ID: 30220545
    [Abstract] [Full Text] [Related]

  • 10. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
    Zhang L, Li R, Shi W, Liang X, Liu S, Ye Z, Yu C, Chen Y, Zhang B, Wang W, Lai Y, Ma J, Li Z, Tan X.
    Br J Pharmacol; 2013 Sep 12; 170(2):426-39. PubMed ID: 23826864
    [Abstract] [Full Text] [Related]

  • 11. The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats.
    Zhang X, Song Z, Guo Y, Zhou M.
    Mol Cell Biochem; 2015 Jan 12; 399(1-2):155-65. PubMed ID: 25292315
    [Abstract] [Full Text] [Related]

  • 12. Protein S Protects against Podocyte Injury in Diabetic Nephropathy.
    Zhong F, Chen H, Xie Y, Azeloglu EU, Wei C, Zhang W, Li Z, Chuang PY, Jim B, Li H, Elmastour F, Riyad JM, Weber T, Chen H, Wang Y, Zhang A, Jia W, Lee K, He JC.
    J Am Soc Nephrol; 2018 May 12; 29(5):1397-1410. PubMed ID: 29511111
    [Abstract] [Full Text] [Related]

  • 13. Circ-0000953 deficiency exacerbates podocyte injury and autophagy disorder by targeting Mir665-3p-Atg4b in diabetic nephropathy.
    Liu X, Jiang L, Zeng H, Gao L, Guo S, Chen C, Liu X, Zhang M, Ma L, Li Y, Qi X, Wu Y.
    Autophagy; 2024 May 12; 20(5):1072-1097. PubMed ID: 38050963
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor 1 knockdown attenuates high glucose-induced podocyte injury by promoting the JAK2/STAT signalling-mediated autophagy.
    Zhang Y, Liu M, Wu Y, Xu Y, Hong Y, Xiang H.
    Nephrology (Carlton); 2024 Jul 12; 29(7):394-404. PubMed ID: 38586891
    [Abstract] [Full Text] [Related]

  • 15. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy.
    Cheng Q, Pan J, Zhou ZL, Yin F, Xie HY, Chen PP, Li JY, Zheng PQ, Zhou L, Zhang W, Liu J, Lu LM.
    Acta Pharmacol Sin; 2021 Jun 12; 42(6):954-963. PubMed ID: 32968210
    [Abstract] [Full Text] [Related]

  • 16. miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury.
    Wang Y, Feng F, He W, Sun L, He Q, Jin J.
    Bioengineered; 2022 Jan 12; 13(1):774-788. PubMed ID: 34847832
    [Abstract] [Full Text] [Related]

  • 17. ATF4-dependent heme-oxygenase-1 attenuates diabetic nephropathy by inducing autophagy and inhibiting apoptosis in podocyte.
    Yuan S, Liang X, He W, Liang M, Jin J, He Q.
    Ren Fail; 2021 Dec 12; 43(1):968-979. PubMed ID: 34157937
    [Abstract] [Full Text] [Related]

  • 18. Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy.
    Barutta F, Bellini S, Kimura S, Hase K, Corbetta B, Corbelli A, Fiordaliso F, Bruno S, Biancone L, Barreca A, Papotti MG, Hirsh E, Martini M, Gambino R, Durazzo M, Ohno H, Gruden G.
    Autophagy; 2023 Feb 12; 19(2):505-524. PubMed ID: 35659195
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux.
    Jin J, Gong J, Zhao L, Zhang H, He Q, Jiang X.
    J Diabetes; 2019 Oct 12; 11(10):826-836. PubMed ID: 30864227
    [Abstract] [Full Text] [Related]

  • 20. MAD2B promotes podocyte injury through regulating Numb-dependent Notch 1 pathway in diabetic nephropathy.
    Li MR, Lei CT, Tang H, Yin XJ, Hao Z, Qiu Y, Xie YR, Zeng JY, Su H, Zhang C.
    Int J Biol Sci; 2022 Oct 12; 18(5):1896-1911. PubMed ID: 35342338
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.